Why the study?
Do refined anticoagulation monitoring techniques improve blood loss and transfusion outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass?
Do refined anticoagulation monitoring techniques improve blood loss and transfusion outcomes in patients undergoing cardiac surgery with cardiopulmonary bypass?
Current literature on anticoagulation monitoring during cardiopulmonary bypass is inconsistent, highlighting the need for more well-controlled studies to determine if refined monitoring techniques improve bleeding and transfusion outcomes.
No takes yet. Share an insight, caveat, or question.
Inconsistent evidence precludes practice changes in ACT monitoring; leaves open whether refined protocols reduce bleeding in cardiac surgery.
Despotis et al. (1999) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: